Specialists for Tuberculosis

60 physicians and care centers identified from ClinicalTrials.gov trial PIs, PubMed publications, and the NPPES NPI registry.

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Susan E Dorman, MD
Rare Disease / Clinical Research
Johns Hopkins University
QC-verified PI×1
John L Johnson, MD
Rare Disease / Clinical Research
Case Western Reserve University
QC-verified PI×1
Wafaa El-Sadr, MD
Rare Disease / Clinical Research
University Professor; Director, ICAP, Department of Epidemiology
NEW YORK, NY
QC-verified PI×1 1
C. Fordham F von Reyn, MD
Rare Disease / Clinical Research
Dartmouth-Hitchcock Medical Center
QC-verified PI×1
Veronique R De Jager, MBChB
Rare Disease / Clinical Research
TASK
QC-verified PI×1
Vladimir Shmelev, Doctor
Rare Disease / Clinical Research
SPP Pharmaclon Ltd.
QC-verified PI×1
Ming-Chih Yu, M.D.
Rare Disease / Clinical Research
Taipei Medical University-Wan Fang Hospital
QC-verified PI×1
Helen McShane
Rare Disease / Clinical Research
University of Oxford
PI×13 2
Awewura Kwara, MD
Rare Disease / Clinical Research
University of Florida
GAINESVILLE, FL
PI×5 1
Isik Somuncu Johansen, Prof
Rare Disease / Clinical Research
Dept. of Infectious Diseases, Odense University Hosp., Univ. of Southern Denmark
PI×1
Deepali Kumar, MD
Rare Disease / Clinical Research
University Health Network, Toronto
PI×1
Pranay Sinha, MD
Rare Disease / Clinical Research
Boston Medical Center
BOSTON, MA
PI×3
Johanna Åhsberg, MD
Rare Disease / Clinical Research
Dept. of Infectious Diseases, Odense University Hosp., Univ. of Southern Denmark
PI×1
Kidist Bobosha, PhD
Rare Disease / Clinical Research
Armauer Hansen Research Institute
PI×1
Pakrash Babu Narasimhan, PhD
Rare Disease / Clinical Research
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)
PI×1
Elmira Ibraim, MD
Rare Disease / Clinical Research
Marius Nasta Pulmonology Institute, Sos. Viilor 90 Sector 5, 050159 Bucharest, Romania
PI×1
Antonio Lombardi, MD
Rare Disease / Clinical Research
TB Alliance
PI×4 1
Carol Holm-Hansen, PhD
Rare Disease / Clinical Research
Norwegian Institute of Public Health
PI×1
Irini Sereti, M.D.
Rare Disease / Clinical Research
National Institute of Allergy and Infectious Diseases (NIAID)
BETHESDA, MD
PI×7
BioNTech Responsible Person
Rare Disease / Clinical Research
BioNTech SE
PI×19
Rina La Distia Nora, MD, PhD
Rare Disease / Clinical Research
Fakultas Kedokteran Universitas Indonesia
PI×1
Ahmad R Ganiem, MD, PhD
Rare Disease / Clinical Research
Hasan Sadikin General Hospital, Bandung, Indonesia
PI×1
Grant Theron, PhD
Rare Disease / Clinical Research
University of Stellenbosch
PI×4
Donna Seminara, MD
Rare Disease / Clinical Research
Staten Island University Hospital
STATEN ISLAND, NY
PI×1
Rany Condos, MD, M.D
Rare Disease / Clinical Research
NYU School of Medicine
NEW YORK, NY
PI×4
catherine GEINDRE
Rare Disease / Clinical Research
Assistance Publique Hopitaux De Marseille
PI×10
Balthazar Nyombi, PhD
Rare Disease / Clinical Research
Kilimanjaro Christian Medical Centre, Tanzania
PI×1
David Shitrit, MD
Rare Disease / Clinical Research
Meir Medical Center
PI×3
Yazdan Yazdanpanah, MD-PHD
Rare Disease / Clinical Research
Assistance Publique - Hôpitaux de Paris
PI×1
Sonya S Shin, MD
Rare Disease / Clinical Research
Brigham and Women's Hospital
GALLUP, NM
PI×1
Novel Chegou, Prof
Rare Disease / Clinical Research
University of Stellenbosch
PI×1
Ajit Lalvani
Imperial College London
QC-verified PI×1
Olivier Marcy
University of Bordeaux, France
QC-verified PI×2
Anne Margarita Dyrhol-Riise
Oslo University Hospital
QC-verified PI×1
Laura Moretó Planas
MSF OCBA
QC-verified PI×1
Dereck Tait
Aeras
QC-verified PI×2
Mark Cotton
University of Stellenbosch
QC-verified PI×3
Alberto Maldonado Hernández
Centro de Salud Colima
QC-verified PI×1
Richard Chaisson, M.D
Johns Hopkins University
BALTIMORE, MD
QC-verified PI×2
Wafaie W Fawzi
Harvard School of Public Health (HSPH)
QC-verified PI×2
Edward Nardell, MD
Brigham and Women's Hospital
BOSTON, MA
QC-verified PI×1
Vanya Dhagat
Lotus Labs
QC-verified PI×1
Sophia B Siddiqui, MD
National Institute of Allergy and Infectious Diseases (NIAID)
BETHESDA, MD
QC-verified PI×2
Michael Hoelscher
LMU University Hospital
QC-verified PI×3
Clifton E Barry, LPC
National Institute of Allergy and Infectious Diseases (NIAID)
SPRINGFIELD, MI
QC-verified PI×6
Birgit Thierry-Carstensen
Statens Serum Institut Denmark
QC-verified PI×1
Sara Browne
University of California, San Diego
QC-verified PI×1
Sathirakorn Pongpanich
Chulalongkorn University
QC-verified PI×1
Dathan Byonanebye Mirembe
Infectious Diseases Institute
QC-verified PI×1
Adrian Martineau, Au.D
Barts and The London School of Medicine and Dentistry, Queen Mary University, University of London
QC-verified PI×1
Ruvandhi Nathavitharana
Beth Israel Deaconess Medical Center
BOSTON, MA
QC-verified PI×1
Shuihua Lu, bachelor
Shenzhen Third People's Hospital
QC-verified PI×2
Mark Hatherill
University of Cape Town, Faculty of Health Sciences
QC-verified PI×3
JongHyun Kim
The Catholic University of Korea St. Vincent's Hospital, Pediatrics
QC-verified PI×1
Naihui Chu
Beijing Chest Hospital affiliated to Capital Medical University
QC-verified PI×1
Zhongkai SHI
Aeras
QC-verified PI×1
Andrew Moss
University of California
QC-verified PI×1
Mada Ferreira
Farmovs-Parexel, Bloemfontein, RSA
QC-verified PI×1
Supot Nimanong
Mahidol University
QC-verified PI×2
Patrick Yeni
Assistance Publique Hopitaux de Paris
QC-verified PI×1

More about Tuberculosis

Disease overview →
Treatments →
Clinical trials →